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Abstract
Background: This study was performed to compare the associations of brachial-ankle pulse wave velocity (baPWV)
and central blood pressure (CBP) measurements with left ventricular (LV) geometry and diastolic function.
Methods: A total of 77 subjects (64.5 ± 10.8 years, 67.5% females) without documented cardiovascular disease were
prospectively recruited. All subjects underwent transthoracic echocardiography, baPWV and noninvasive
measurement of CBP on the same day.
Results: In simple linear correlation analyses, neither baPWV nor CBP was associated with LV mass index or
relative wall thickness (P > 0.05 for each). Although baPWV significantly correlated with septal e´ velocity in
simple linear correlation analyses (r = 0.258, P = 0.025), the significance was lost after controlling for potential
confounder (P = 0.881). In simple linear correlation analyses, central systolic blood pressure (CSBP) and central
pulse pressure (CPP) significantly correlated with both septal e´ velocity or E/e´ (P < 0.05 for each); however,
neither central diastolic nor mean arterial pressures was associated with both septal e´ velocity and E/e´ (P >
0.05 for each). After controlling for confounders, including age, sex and body mass index, CSBP correlated
with septal e´ velocity (β = − 0.258, P = 0.025), but not with E/e´ (P = 0.074). CPP correlated with both septal e´
velocity (β = − 0.300, P = 0.014) and E/e´ (β = 0.428, P = 0.002) in the same multivariable model.
Conclusions: In subjects without documented cardiovascular disease, CSBP and CPP may be more strongly
associated with LV diastolic function than baPWV. Further studies with a larger sample size are needed to
confirm our results.
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Background
Arteries stiffen with age, and cardiovascular diseases
progress [1]. Information on arterial stiffness is clinically
important in that it is associated with future cardiovas-
cular events and mortality, independently of traditional
risk factors [2–4]. Among several types of methods to
measure arterial stiffness, pulse wave velocity (PWV) has
been most widely used [5].
Central blood pressure (CBP) is the pressure in the as-
cending aorta, just outside of the left ventricle (LV).
Based on the fact that major vital organs, such as the
heart and the brain, are more closely exposed to CBP
than to brachial blood pressure (BrBP), emerging evi-
dence has suggested that CBP is more predictive of fu-
ture cardiovascular events than BrBP [6–8]. Also, CBP
has been shown to be more closely associated with sub-
clinical target organ damage, such as left ventricular
(LV) hypertrophy and carotid atherosclerosis, than BrBP
[7–9]. For these reasons, CBP measurement may be
valuable in clinical practice. Although an invasive
hemodynamic study is the gold standard for CBP meas-
urement, it is not feasible in routine practice due to its
invasiveness, cost and time. Fortunately, radial artery
applanation tonometry, a recently developed noninvasive
method, showed a strong correlation with invasively
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measured CBP (10) and is well-validated in many studies
[6, 10].
It has been suggested that there was a close interaction
between the LV and the aorta [11–15]. Arterial stiffening
augments central systolic and pulse pressure (CSBP and
CPP, respectively) leading to LV hypertrophy and LV dia-
stolic dysfunction. Also, decreased central diastolic
blood pressure (CDBP) in a stiffened aorta reduces cor-
onary perfusion [15]. Although both arterial stiffness
and CBP have a significant impact on the LV, most of
the prior studies have only focused on arterial stiffness
or CBP. It is of clinical value in patient management to
find out what parameter affects the LV in the same sub-
ject. However, it has not been studied yet. Therefore, this
study was performed to compare the associations of bra-
chial-ankle pulse wave velocity (baPWV) and CBP mea-
surements with LV geometry and diastolic function.
Methods
Study population
Between January and March 2018, consecutive adult
subjects (≥ 18 years) who visited Seoul Metropolitan
Government Seoul National University Boramae Medical
Center (Seoul, Korea) for cardiovascular examinations
were prospectively enrolled in this study. Subjects were
eligible if they had been never diagnosed with myocar-
dial infarction, angina requiring revascularization, heart
failure, peripheral arterial disease or stroke. Subjects
with the following clinical conditions were also excluded:
1) unstable vital signs, 2) left ventricular ejection fraction
< 50%, 3) valvular regurgitation or stenosis of mild de-
gree and greater, 4) uncontrolled arrhythmia, and 5)
ankle-brachial index < 0.9 or > 1.4. The study protocol
was approved by the Institutional Review Board of Bora-
mae Medical Center (Seoul, Korea). Written informed
consent was obtained from each study subject.
Data collection
Body mass index (BMI) was calculated by dividing
body weight (kg) by the square of body height (m).
Hypertension was defined as systolic blood pres-
sure ≥ 140 mmHg, diastolic blood pressure ≥ 90
mmHg, previous diagnosis of hypertension, or the
use of antihypertensive medications. Diabetes melli-
tus, was defined as fasting glucose ≥ 126 mg/dL, pre-
vious diagnosis of diabetes mellitus or the use of
anti-diabetic medications. Dyslipidemia was defined
as low-density lipoprotein cholesterol ≥ 160 mg/dL,
previous diagnosis of dyslipidemia, or the use of
anti-dyslipidemic medications. Subjects were classi-
fied as smokers if they had smoked within the recent
12 months. All subjects underwent laboratory tests
with venous blood taken in the morning after over-
night fasting. White blood cell (WBC) count and
hemoglobin concentration as well as serum levels of
fasting glucose, total cholesterol, low-density lipopro-
tein (LDL) cholesterol, high-density lipoprotein
(HDL) cholesterol, triglyceride, glycated hemoglobin
(HbA1c) creatinine, and C-reactive protein were
measured by an automated enzymatic procedure. Es-
timated glomerular filtration rate was calculated
using the 4-component Modification of Diet in Renal
Disease (MDRD) study equation incorporating age,
race, sex, and serum creatinine level [16]. Data on
cardiovascular medications, including calcium chan-
nel blocker, beta-blocker, angiotensin receptor
blocker and statin, was also collected.
baPWV measurement
The volume-plethysmographic apparatus (VP-2000;
Colin Co., Ltd., Komaki, Japan) was used for the meas-
urement of baPWV. Each baPWV was measured in ac-
cordance with the manufacturer’s instructions [17, 18].
Caffeine consumption, cigarette smoking, and alcohol
consumption were prohibited before baPWV measure-
ment on the study day. Each subject rested in the supine
position in a quiet room for at least 5 min before the
measurement. Electrocardiographic electrodes were ap-
plied to both wrists, phonocardiographic electrodes were
placed on the edge of the sternum to detect heart
sounds, and pneumatic cuffs were wrapped on both
upper arms and ankles. PWV was calculated by dividing
distance by transit time. The distance between measure-
ment points of baPWV was estimated by subject height.
Transit time was calculated from the start point of the
brachial pulse wave to the start of the ankle pulse wave.
The average value of left and right baPWV measure-
ments was used for the study. The coefficient of variance
for inter-observer reliability of baPWV was 5.1% in our
laboratory [19].
CBP measurement
Immediately after baPWV measurement, CBP measure-
ment was conducted using a commercially available ra-
dial artery applanation tonometry (HEM-9000AI;
Omron Healthcare, Kyoto, Japan) [20]. Left radial artery
pressure waveforms and right brachial blood pressure
were simultaneously measured after resting in the sitting
position for ≥ 5 min. Then, we obtained the first and
second peaks of peripheral systolic pressure (SBP1 and
SBP2), respectively by calibrating the radial waveform
with brachial systolic blood pressure. Finally, CBP was
automatically calculated with a linear equation for SBP2
[21]. Pulse pressure (PP) was defined as the difference
between systolic and diastolic blood pressures (SBP and
DBP, respectively).
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Transthoracic echocardiography (TTE)
TTE was performed on the same day of CBP measure-
ment. TTE was performed using commercially available
devices (Sequoia; Siemens Medical Solutions, Mountain
View, CA, USA or Vivid 7; GE Medical Systems, Mil-
waukie, WI, USA) according to the recommendations of
the current guidelines [22, 23]. LV dimensions were
measured on the parasternal short-axis view using M-
mode echocardiography, and LV ejection fraction was
measured on the apical 4- and 2-chamber views using
the biplane Simpson’s method. Relative wall thickness
(RWT) was defined as 2 times posterior wall thickness
divided by LV diastolic diameter, and the LV mass was
calculated using a validated formula and indexed to the
body surface area (LV mass index [LVMI]) [22]. All pa-
tients received pulsed wave Doppler examination at the
tip of the mitral leaflets to measure peak early mitral in-
flow velocity during early diastole (E), late diastole (A),
and deceleration time. Color-coded tissue Doppler im-
aging was performed on the apical 4-chamber view to
calculate early velocity (e′) at the septal mitral annulus.
Left atrial volume index (LAVI) was measured with the
biplane method on the apical 4- and 2-chamber views at
ventricular end-systolic phases [23]. LV diastolic func-
tion was assessed using abnormal cutoff values (septal e
′ < 7 cm/sec and E/e′ ≥ 15) recommended by the guide-
line [23]. Inter-observer agreements of septal e′ and E/e′
were evaluated by Pearson’s correlation among 50 sub-
jects. The correlation coefficients were 0.96 and 0.92 for
e′ and E/e′, respectively, in our laboratory [24].
Statistical analysis
The continuous variables are presented as mean ± SD,
and categorical variables are expressed as percentages.
Univariate associations between 2 parameters were
assessed using simple linear regression analyses. Multi-
variable linear regression analysis was subsequently ap-
plied to examine independent relationships between
individual parameters that had significant associations in
univariate analyses. Age, sex, and BMI were adjusted
during multivariable analyses. Scatter plots were used
for the demonstration of linear correlations between 2
parameters. Correlations were compared using Meng’s Z
test [25]. A P value of < 0.05 was considered statistically
significant. All statistical analyses were conducted using
SPSS 22.0 (IBM Corp., Armonk, NY, USA).
Results
Clinical characteristics of the study subjects
Clinical characteristics of the study subjects are pre-
sented in Table 1. Mean age was 64.5 ± 10.8 years, and
67.5% were female. The prevalence rates of hyperten-
sion, diabetes mellitus, and dyslipidemia were 48.1, 19.5,
and 36.4%, respectively. Approximately one-fourth of the
patients (26.0%) were current smokers. The mean value
of WBC count, hemoglobin concentration, serum level
of total cholesterol, LDL cholesterol, HDL cholesterol,
triglyceride, HbA1c, glomerular filtration rate, and C-re-
active protein were within the normal range. The pro-
portion of subjects taking calcium channel blocker, beta-
blocker, renin-angiotensin system blocker, and statin
were 13.0, 16.9, 7.8, and 15.6%, respectively. Results of
TTE, baPWV,. and CBP are shown in Table 2. All these
parameters were within normal limits. The mean value
of baPWV was 1,512 ± 299 cm/s, and the mean values of
central SBP and DBP were 137 ± 19 and 78.3 ± 9.7
mmHg, respectively.
Associations of arterial stiffness and CBP with LV
geometry and diastolic function
Univariable and multivariable analyses showing the associ-
ations of arterial stiffness and CBP with LV geometry and
diastolic function are demonstrated in Table 3. The
baPWV was not associated with LV geometric parameters,
such as RWT or LVMI, in simple linear correlation ana-
lyses (P > 0.05 for each). It correlated with e′ velocity in
simple correlation analysis (r = − 0.258, P = 0.025);
Table 1 Clinical characteristics of study subjects
Characteristic Value (n = 77)
Age, years 64.5 ± 10.8
Female sex, n (%) 52 (67.5)
Body mass index, kg/m2 25.0 ± 3.7
Cardiovascular risk factors, n (%)
Hypertension 37 (48.1)
Diabetes mellitus 15 (19.5)
Dyslipidemia 28 (36.4)
Cigarette smoking 20 (26.0)
Laboratory findings
White blood cell count, per microliter 6,276 ± 1,772
Hemoglobin, g/dL 13.6 ± 1.8
Total cholesterol, mg/dL 174 ± 37
LDL cholesterol, mg/dL 102 ± 34
HDL cholesterol, mg/dL 52.9 ± 12.0
Triglyceride, mg/dL 121 ± 76
HbA1c, % 5.97 ± 0.98
Glomerular filtration rate, mL/min/1.73m2 88.2 ± 20.5
Glomerular filtration rate < 60 mL/min/1.73m2, n (%) 4 (5.2)
C-reactive protein, mg/dL 0.35 ± 0.92
Concomitant medications, n (%)
Calcium channel blocker 10 (13.0)
Beta-blocker 13 (16.9)
Angiotensin receptor blocker 6 (7.8)
Statin 12 (15.6)
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however, the statistical significance disappeared in multi-
variable analysis (P = 0.881). CSBP correlated with e′ vel-
ocity (r = − 0.386, P = 0.001) and E/e′ (r = 0.314, P =
0.003), but not with RWT (P = 0.768) or LVMI (P = 0.869)
in simple correlation analyses. In multivariable analysis
after controlling for confounding effects of age, sex, and
BMI, the statistical significance remained in the associ-
ation between CSBP and e′ velocity (r = − 0.239, P =
0.025), but not in the association between CSBP and E/e′
(r = 0.212, P = 0.074). Neither CDBP nor CMAP was not
associated with RWT, LVMI, e′ velocity, or E/e′ in simple
correlation analyses (P > 0.05 for each). CPP correlated
with e′ velocity (r = − 0.490, P < 0.001) and E/e′ (r = 0.566,
P < 0.001), but not with RWT (P = 0.984) or LVMI (P =
0.333) in simple correlation analyses. The statistical signifi-
cances in the associations of CPP with e′ velocity (β = −
0.300, P = 0.014) and E/e′ (β = 0.428, P = 0.002) remained
even after controlling for age, sex, and BMI in multivariable
analyses. The linear correlations of baPWV and CPP with
E/e′ are demonstrated in Fig. 1. Brachial PP also showed a
significant correlation with E/e′ (r = 0.454, P < 0.001). The
correlation coefficient was numerically smaller between
brachial PP and E/e′ than between CPP and E/e′, although
it was statistically insignificant (P for difference = 0.111)
(Fig. 2).
Discussion
The main findings of the present study are: 1) there were
lack of associations of both baPWV and CBP with LV
geometry; and 2) CSBP and CPP, but not baPWV, were
associated with LV diastolic function. To the best of our
knowledge, this is the first report showing more power-
ful association of CBP with LV diastolic function com-
pared to arterial stiffness in the same subject.
Association between CBP and LV diastolic function
The association between CBP and LV diastolic function
has been reported. Previously, our group has reported a
significant association between invasively measured pul-
satile pressure of the central aorta and LV diastolic pa-
rameters in 153 patients undergoing invasive coronary
Table 2 Results of echocardiography and measurements of
arterial stiffness and blood pressure
Parameter Value (n = 77)
Echocardiography
Left ventricular end-diastolic dimension, mm 47.8 ± 5.0
Left ventricular end-systolic dimension, mm 29.8 ± 5.8
Left ventricular ejection fraction, % 66.2 ± 5.4
Relative wall thickness 0.35 ± 0.04
Left ventricular mass index, g/m2 82.9 ± 21.2
E/A 0.87 ± 0.36
Deceleration time, ms 219 ± 50
Septal e’ velocity, cm/s 6.46 ± 4.31
Septal E/e’ 11.4 ± 4.4
Left atrial volume index, mL/m2 33.1 ± 11.0
Maximal velocity of tricuspid regurgitation flow, m/s 2.24 ± 0.33
Brachial ankle pulse wave velocity, cm/s 1,512 ± 299
Blood pressure measurements
Brachial systolic blood pressure, mmHg 131 ± 18
Brachial diastolic blood pressure, mmHg 76.1 ± 9.9
Brachial mean arterial pressure, mmHg 94.6 ± 12.0
Brachial pulse pressure, mmHg 55.6 ± 12.5
Central systolic blood pressure, mmHg 137 ± 19
Central diastolic blood pressure, mmHg 78.3 ± 9.7
Central mean arterial pressure, mmHg 98.0 ± 11.2
Central pulse pressure, mmHg 59.0 ± 15.9
Table 3 Associations of brachial-ankle pulse wave velocity and
central blood pressure measurements with parameters of left
ventricular geometry and diastolic function
Parameter Simple Multivariablea
r P β P
brachial-ankle pulse wave velocity
Relative wall thickness 0.116 0.316 – –
Left ventricular mass index −0.071 0.547 – –
e´ velocity −0.258 0.025 − 0.017 0.881
E/e´ 0.194 0.094 – –
Central systolic blood pressure
Relative wall thickness 0.034 0.768 – –
Left ventricular mass index 0.019 0.869 – –
e´ velocity −0.386 0.001 −0.239 0.025
E/e´ 0.341 0.003 0.212 0.074
Central diastolic blood pressure
Relative wall thickness 0.063 0.588 – –
Left ventricular mass index −0.135 0.250 – –
e´ velocity 0.054 0.640 – –
E/e´ −0.161 0.101 – –
Central mean arterial pressure
Relative wall thickness 0.055 0.633 – –
Left ventricular mass index −0.069 0.558 – –
e´ velocity −0.187 0.105 – –
E/e´ 0.101 0.385 – –
Central pulse pressure
Relative wall thickness 0.002 0.984 – –
Left ventricular mass index 0.113 0.333 – –
e´ velocity −0.490 < 0.001 −0.300 0.014
E/e´ 0.566 < 0.001 0.428 0.002
a Age, sex and body mass index are adjusted in this model
Kim et al. Clinical Hypertension           (2019) 25:18 Page 4 of 8
angiography [24]. Shim et al. [11] measured CBP using
radial artery tonometry and showed that CPP amplifica-
tion was independently associated with e′ velocity in
women. A study of 1,233 community subjects demon-
strated that CPP was associated with e′ velocity and E/e
′ ratio [13]. A recent longitudinal study of 607 subjects
found that the increased E/e′ ratio during the 4.7 years
of follow-up was independently related to baseline CPP
measured by radial artery tonometry in women [26]. In
line with these studies, our study showed the association
of CSBP and CPP with e′ velocity, which supports the
concept of ventricular-arterial relationship [15, 27, 28].
Increased CSBP represents increased LV afterload, which
may slow LV relaxation. Additionally, widening of CPP
with decreased CDBP reduces coronary perfusion during
LV diastole, causing further impairment of myocardial
relaxation [15, 29].
Lack of the association between baPWV and LV diastolic
function
There have been several studies reporting the association
of arterial stiffness measured by baPWV with LV diastolic
function. Analysis of 320 subjects with various abnormal-
ities of cardiac structure and function have suggested that
baPWV correlates with parameters of LV structure and
function such as LV mass and mitral e′ velocity [30].
Wang et al. [31] reported that baPWV was independently
and negatively associated with e′ velocity in 42 hyperten-
sive subjects. In apparently healthy 115 subjects, there was
a significant correlation between baPWV and E/e′ [32].
Fig. 1 The correlations of central pulse pressure and brachial-ankle PWV with Ee/'. PWV, pulse wave velocity
Fig. 2 The correlations of central and brachial pulse pressures with E/e'
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Similarly, Kang et al. [33] investigated 2,095 community
subjects and showed an independent association between
baPWV and LV diastolic dysfunction. A previous study
confirmed that baPWV was significantly associated with
E/A ratio among healthy adults with normal LV ejection
fraction [34]. On the contrary, the results of the present
study showed that baPWV correlated with septal e′ vel-
ocity in univariable analyses; however, the significance of
this correlation disappeared after controlling for age, sex,
and BMI. It is thought that a different study population
and a small sample size might be the main reason for the
negative findings of our study. Further studies with a lar-
ger sample size are needed to determine the utility of
baPWV and CBP in the prediction of LV diastolic
function.
Clinical implications
A novel finding of our study is that CBP more affects
LV diastolic function than arterial stiffness. This may
suggest the importance of CBP as an indicator of LV
diastolic dysfunction, which provides an additional
insight in the interaction between LV and the arterial
system. Given that LV diastolic dysfunction is associ-
ated with worse clinical outcomes [35, 36], CBP
measurement may have more important implications
for risk stratification than baPWV. CBP may be a
good monitoring tool to assess LV diastolic dysfunc-
tion. In addition, revealing the degree of relationships
between baPWV and CBP may be particularly import-
ant for treatment strategies. Targeting CBP may be
more effective in reduction in patient risk than target-
ing baPWV. The potential targeted therapy should be
explored to reduce CBP for the restoration of LV dia-
stolic dysfunction or the prevention of heart failure.
Moreover, there is lack of corroborative evidence that
CBP reduction leads to the improvement in cardio-
vascular outcomes. Further prospective studies are
needed to confirm this.
Study limitations
There are several limitations to this study. First, it is
difficult to prove the causal relationship between
CBP and LV diastolic function in this cross-sectional
study. Secondly, there was the possibility that the
small sample size of our study could not draw statis-
tical significance in the relationships between
baPWV and LV diastolic parameters, and between
baPWV/CBP and LV geometry. For the same reason,
some potential confounders, such as medications, could
not be controlled during multivariable analyses. Also, al-
though sex differences in ventricular-arterial relationships
have been an issue [11, 26], sex-specific analysis could not
be performed due to the small number of study subjects.
Thirdly, baPWV was used as a measure of arterial stiffness
in our study, instead of carotid-femoral PWV
(cfPWV), a gold standard noninvasive measure of ar-
terial stiffness [37]. However, baPWV has been shown
to be strongly associated with cfPWV [38] and inva-
sively measured aortic PWV [39]. In some studies,
baPWV better correlated with LV mass and diastolic
function than cfPWV [30]. Since baPWV includes
both central and peripheral arterial stiffness, and
cfPWV mainly reflects only central arterial stiffness,
baPWV may be more representative of an arterial
load of the LV than cfPWV [40]. Therefore, baPWV
can be used as an indicator of arterial stiffness. Fi-
nally, our study subjects were middle-aged or older
and without overt cardiovascular disease, so that our
results cannot be generalized to other groups of sub-
jects with different demographics and risk factors.
Conclusions
In middle-aged or older subjects without overt cardio-
vascular disease, CSBP and CPP were more strongly as-
sociated with LV diastolic function than baPWV.
Measurement of CBP rather than baPWV may be more
useful for the risk stratification and management of
these age groups of subjects. Further studies with a lar-
ger sample size are warranted.
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